Albumin is synthesized by the liver, but serum concentration is affected by inflammatory signaling, capillary permeability, dilution, renal/GI losses, liver synthetic capacity, and chronic disease. It is a negative acute-phase reactant and often reflects illness burden rather than isolated inadequate protein intake.
CLINICAL PRINTABLE
Coming Soon.
Coming Soon. A one-page Low Albumin clinical reference is on the way.
1 · Interpretation Framework
- Albumin is the most abundant plasma protein, synthesized exclusively by the liver. It maintains oncotic pressure, transports hormones and drugs, and serves as a buffer.
- Albumin is a negative acute-phase reactant — IL-6 and other inflammatory cytokines suppress hepatic albumin synthesis during systemic illness, independent of nutritional intake.
- Normal albumin: 3.5–5.0 g/dL. Mild hypoalbuminemia: 3.0–3.5 g/dL. Moderate: 2.5–3.0 g/dL. Severe: < 2.5 g/dL.
- Albumin has a half-life of approximately 20 days — it is a slow-moving marker that reflects chronic or sustained processes, not acute nutritional changes.
- Mechanisms of hypoalbuminemia: decreased synthesis (liver disease, inflammation), increased losses (nephrotic syndrome, protein-losing enteropathy, burns, exudative wounds), dilution (fluid overload, aggressive IV hydration), and malnutrition (a contributing factor, but rarely the sole cause in hospitalized patients).
- Albumin is a prognostic marker in many conditions — low albumin correlates with worse outcomes in surgery, critical illness, cirrhosis, and malignancy. It reflects illness burden, not just nutrition.
2 · Nuance
Inflammation suppresses albumin synthesis
In acute illness, surgery, or chronic inflammatory states, IL-6 and other cytokines directly suppress hepatic albumin production. This is the most common cause of low albumin in hospitalized patients — not inadequate protein intake.
Nephrotic syndrome
Heavy proteinuria (> 3.5 g/day) causes significant albumin loss in urine. Nephrotic syndrome presents with hypoalbuminemia, edema, hyperlipidemia, and lipiduria. Check urine protein/creatinine ratio when the mechanism is unclear.
Protein-losing enteropathy
GI protein loss (from IBD, lymphangiectasia, or other enteropathies) can cause hypoalbuminemia despite adequate intake. Alpha-1 antitrypsin stool clearance can help identify GI protein loss.
Dilutional hypoalbuminemia
Aggressive IV fluid resuscitation, ascites, and third-spacing dilute albumin concentration without true protein depletion. Volume status assessment is essential before attributing low albumin to synthesis failure or loss.
Drug binding implications
Many drugs are highly protein-bound (phenytoin, warfarin, calcium). Hypoalbuminemia increases the free fraction of these drugs — apparent 'normal' total levels may mask elevated free (active) drug concentrations. Corrected calcium and free phenytoin levels are clinically important.
3 · What Should Raise Concern
- Albumin < 2.5 g/dL with edema, ascites, or pleural effusions — assess for nephrotic syndrome, cirrhosis, or protein-losing enteropathy as the primary cause.
- Low albumin with elevated INR and bilirubin — suggests hepatic synthetic failure. Hepatology consultation is warranted.
- Rapidly falling albumin in a hospitalized patient — often reflects worsening systemic inflammation or new protein loss, not acute nutritional decline.
- Low albumin with heavy proteinuria — nephrotic syndrome workup is needed, including renal function, lipid panel, and nephrology referral.
4 · What Do I Do Next?
- Identify the mechanism: decreased synthesis (liver disease, inflammation), increased loss (renal, GI), dilution, or malnutrition — the approach differs for each.
- Check urine protein/creatinine ratio when nephrotic syndrome is suspected — heavy proteinuria changes the diagnosis and management entirely.
- Assess liver synthetic function (INR, bilirubin) if hepatic cause is suspected — albumin alone does not distinguish acute from chronic liver disease.
- Correct calcium for albumin: corrected calcium = measured calcium + 0.8 × (4.0 − albumin). This is essential before treating apparent hypocalcemia.
- Nutritional assessment is appropriate when malnutrition is suspected — but do not attribute low albumin to nutrition alone in an acutely ill patient without ruling out inflammatory and loss-based mechanisms.
Apply It · Patient Cases
CASE 1
A 58-year-old is admitted with sepsis from pneumonia. Albumin on admission is 2.8 g/dL. Nutrition consult is called. However, the patient was eating normally before admission — the hypoalbuminemia reflects acute-phase suppression of albumin synthesis from systemic inflammation, not malnutrition. Nutritional support is appropriate, but the albumin will not normalize until the inflammatory state resolves.
CASE 2
A 34-year-old presents with bilateral leg edema and frothy urine. Albumin is 1.9 g/dL. Urine protein/creatinine ratio is 8.2 g/g. Nephrotic syndrome is diagnosed. The hypoalbuminemia is driven by urinary protein loss — not liver disease or malnutrition. Nephrology is consulted.
NOW CHANGE ONE DETAIL
Same patient as Case 2, but urine protein is normal. The hypoalbuminemia without proteinuria prompts evaluation for liver synthetic failure and protein-losing enteropathy. INR and bilirubin are checked; GI workup follows.
Bottom Line
Low albumin is a context marker, not a standalone nutrition test. Identify the mechanism — inflammation, renal loss, hepatic failure, or dilution — before attributing it to diet.
EVIDENCE & REFERENCES
- Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448–454. doi:10.1056/NEJM199902113400607
- Nicholson JP, et al. The role of albumin in critical illness. Br J Anaesth. 2000;85(4):599–610. doi:10.1093/bja/85.4.599
- Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Int Suppl. 2012;2(2):139–274. doi:10.1038/kisup.2012.9